Voxvoganan Coating Integration
Prevention of device-related healthcare-associated infections
Pre-clinicalActive
Key Facts
Indication
Prevention of device-related healthcare-associated infections
Phase
Pre-clinical
Status
Active
Company
About Amicoat
Amicoat is a private, preclinical-stage biotech company pioneering antimicrobial peptide (AMP) coatings for medical devices to combat healthcare-associated infections (HAIs) and antimicrobial resistance (AMR). Its core asset is voxvoganan, a proprietary AMP effective against over 250 microbes, including antibiotic-resistant strains. The company operates a B2B partnership model, supporting device manufacturers in integrating its technology, and is backed by notable Norwegian investors like Kistefos AS.
View full company profile